Tag:
San Francisco
Latest Headlines
Latest Headlines
Non-stem cell treatment rebuilds heart muscle in a mouse
Scientists at Duke University used microRNAs to convert fibroblasts/scar tissue into heart muscle cells in a mouse, boosting the heart's ability to do its job.
Computer-based discovery biotech from Israel lands in Bay Area
Tel Aviv-based Compugen has opened shop in a promised land of biotech, South San Francisco.
Nektar boosts R&D presence in San Francisco
Nektar Therapeutics ( $NKTR ) has announced a move to consolidate all of its U.S. research and development at its Mission Bay location in San Francisco.
Biotech building boom restricted to top "micro" hot spots
The restructuring of Big Pharma's pipeline activities around the world is fueling an R&D building boom in the U.S. According to McGraw-Hill, construction starts overall were down three percent in
Pfizer commits $100M to Mission Bay project
Pfizer is taking another shot at opening a research center in San Francisco's Mission Bay. The world's largest drugmaker is committing $100 million dollars over the next 5 years to partner with
San Francisco arm-twisting yields pharma-funded drug take-back pilot
The pharma industry is funding a drug take-back program in which San Francisco police stations will become drop-off points for household medication, and participating pharmacies will collect other
Bayer to open Innovation Center in Pfizer's old SF digs
To help in its hunt for new collaborators active in hematology, oncology, cardiology, diagnostics and women's health, Bayer is planning to open a U.S. Innovation Center and relocate 65 of its
Bayer to open biotech Innovation Center in Pfizer's old SF digs
To help in its hunt for new biotech collaborators active in hematology, oncology, cardiology, diagnostics and women's health, Bayer HealthCare is planning to open a U.S. Innovation Center and
SF execs call for new incentives to boost biotech
The Bay Area biomedical sector nudged up total employment by 539 jobs last year, according to a new survey. And while that gives the San Francisco area bragging rights as the biggest life sciences
SF developers blueprint $1B biotech campus
South San Francisco may be suffering from high commercial vacancy rates, but Shorenstein Properties and SKS Investments have reached a deal with the city to begin building a billion dollars worth of
